Prof. Fabio A. Recchia directs a laboratory in Italy, where his group is testing new biological
therapies in pig models of myocardial infarction and hibernated myocardium, and a laboratory in
the USA focused on the pathogenic role of cardiac metabolic alterations in a canine model of
congestive heart failure. His main expertise is in integrative cardiovascular physiology and
pathophysiology.

Horton JL,…. Recchia FA*, Kelly DP*. The failing heart utilizes 3-hydroxybutyrate as a metabolic stress
defense. JCI Insight. 2019;4(4):e124079.

Gabisonia K,....Recchia FA*, Giacca*. MicroRNA therapy stimulates uncontrolled cardiac repair after
myocardial infarction in pigs. Nature. 2019; 569(7756):418-422.

Tu C, ….Recchia FA, Wu JC. Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction.
Nat Biomed Eng. 2023 Nov 27. Online ahead of print.